Abstract
Seizures have been reported in two families with myoclonus-dystonia due to epsilon-sarcoglycan (SGCE) mutations. We report a Norwegian family with myoclonus-dystonia and epilepsy associated with a novel SGCE mutation. All six manifesting SGCE mutation carriers had myoclonus, and dystonia was present in two patients. Sequencing of the SGCE gene in the proband identified a novel frameshift c.372delG mutation that predicts the amino acid change [p.Lys125SerfsX7] and the formation of a premature stop codon. The mutation segregated with myoclonus-dystonia in the family. The typical motor symptoms were accompanied by generalized seizures in four of six affected mutation carriers. The seizure type included febrile, absence and generalized tonic–clonic seizures. One deceased patient with severe epilepsy and myoclonus could not be tested for the SGCE mutation. Seizures are rarely observed in myoclonus-dystonia patients with SGCE mutations, and may not be a part of the phenotype. The co-occurrence of seizures and myoclonus-dystonia suggests that they are both due to the same underlying SGCE mutation. However, with epilepsy being a relatively common disorder and lack of complete co-segregation in our and previous families, it is possible that some patients suffer from two different genetic disorders. The presence of seizures and EEG abnormalities should not be considered exclusion criteria for the diagnosis of myoclonus-dystonia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ritz K, Gerrits MC, Foncke EM, van Ruissen F, van der Linden C, Vergouwen MD, Bloem BR, Vandenberghe W, Crols R, Speelman JD, Baas F, Tijssen MA (2009) Myoclonus-dystonia: clinical and genetic evaluation of a large cohort. J Neurol Neurosurg Psychiatry 80(6):653–658. doi:10.1136/jnnp.2008.162099
Zimprich A, Grabowski M, Asmus F, Naumann M, Berg D, Bertram M, Scheidtmann K, Kern P, Winkelmann J, Muller-Myhsok B, Riedel L, Bauer M, Muller T, Castro M, Meitinger T, Strom TM, Gasser T (2001) Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 29(1):66–69. doi:10.1038/ng709
Roze E, Apartis E, Clot F, Dorison N, Thobois S, Guyant-Marechal L, Tranchant C, Damier P, Doummar D, Bahi-Buisson N, Andre-Obadia N, Maltete D, Echaniz-Laguna A, Pereon Y, Beaugendre Y, Dupont S, De Greslan T, Jedynak CP, Ponsot G, Dussaule JC, Brice A, Durr A, Vidailhet M (2008) Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 70(13):1010–1016. doi:10.1212/01.wnl.0000297516.98574.c0
Tezenas du Montcel S, Clot F, Vidailhet M, Roze E, Damier P, Jedynak CP, Camuzat A, Lagueny A, Vercueil L, Doummar D, Guyant-Marechal L, Houeto JL, Ponsot G, Thobois S, Cournelle MA, Durr A, Durif F, Echenne B, Hannequin D, Tranchant C, Brice A (2006) Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes. J Med Genet 43(5):394–400. doi:10.1136/jmg.2005.036780
Asmus F, Zimprich A, Tezenas Du, Montcel S, Kabus C, Deuschl G, Kupsch A, Ziemann U, Castro M, Kuhn AA, Strom TM, Vidailhet M, Bhatia KP, Durr A, Wood NW, Brice A, Gasser T (2002) Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol 52(4):489–492. doi:10.1002/ana.10325
Gerrits MC, Foncke EM, de Haan R, Hedrich K, van de Leemput YL, Baas F, Ozelius LJ, Speelman JD, Klein C, Tijssen MA (2006) Phenotype-genotype correlation in Dutch patients with myoclonus-dystonia. Neurology 66(5):759–761. doi:10.1212/01.wnl.0000201192.66467.a3
Nardocci N, Zorzi G, Barzaghi C, Zibordi F, Ciano C, Ghezzi D, Garavaglia B (2008) Myoclonus-dystonia syndrome: clinical presentation, disease course, and genetic features in 11 families. Mov Disord 23(1):28–34. doi:10.1002/mds.21715
Peall KJ, Smith DJ, Kurian MA, Wardle M, Waite AJ, Hedderly T, Lin JP, Smith M, Whone A, Pall H, White C, Lux A, Jardine P, Bajaj N, Lynch B, Kirov G, O’Riordan S, Samuel M, Lynch T, King MD, Chinnery PF, Warner TT, Blake DJ, Owen MJ, Morris HR (2013) SGCE mutations cause psychiatric disorders: clinical and genetic characterization. Brain 136(Pt 1):294–303. doi:10.1093/brain/aws308
Valente EM, Edwards MJ, Mir P, DiGiorgio A, Salvi S, Davis M, Russo N, Bozi M, Kim HT, Pennisi G, Quinn N, Dallapiccola B, Bhatia KP (2005) The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 64(4):737–739. doi:10.1212/01.WNL.0000151979.68010.9B
Grunewald A, Djarmati A, Lohmann-Hedrich K, Farrell K, Zeller JA, Allert N, Papengut F, Petersen B, Fung V, Sue CM, O’Sullivan D, Mahant N, Kupsch A, Chuang RS, Wiegers K, Pawlack H, Hagenah J, Ozelius LJ, Stephani U, Schuit R, Lang AE, Volkmann J, Munchau A, Klein C (2008) Myoclonus-dystonia: significance of large SGCE deletions. Hum Mutat 29(2):331–332. doi:10.1002/humu.9521
Muller B, Hedrich K, Kock N, Dragasevic N, Svetel M, Garrels J, Landt O, Nitschke M, Pramstaller PP, Reik W, Schwinger E, Sperner J, Ozelius L, Kostic V, Klein C (2002) Evidence that paternal expression of the epsilon-sarcoglycan gene accounts for reduced penetrance in myoclonus-dystonia. Am J Hum Genet 71(6):1303–1311. doi:10.1086/344531
Grabowski M, Zimprich A, Lorenz-Depiereux B, Kalscheuer V, Asmus F, Gasser T, Meitinger T, Strom TM (2003) The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 11(2):138–144. doi:10.1038/sj.ejhg.5200938
Weissbach A, Kasten M, Grunewald A, Bruggemann N, Trillenberg P, Klein C, Hagenah J (2013) Prominent psychiatric comorbidity in the dominantly inherited movement disorder myoclonus-dystonia. Parkinsonism Relat Disord. doi:10.1016/j.parkreldis.2012.12.004
Foncke EM, Klein C, Koelman JH, Kramer PL, Schilling K, Muller B, Garrels J, de Carvalho Aguiar P, Liu L, de Froe A, Speelman JD, Ozelius LJ, Tijssen MA (2003) Hereditary myoclonus-dystonia associated with epilepsy. Neurology 60(12):1988–1990
O’Riordan S, Ozelius LJ, de Carvalho Aguiar P, Hutchinson M, King M, Lynch T (2004) Inherited myoclonus-dystonia and epilepsy: further evidence of an association? Mov Disord 19(12):1456–1459. doi:10.1002/mds.20224
Chung EJ, Lee WY, Kim JY, Kim JH, Kim GM, Ki CS, Kim IS (2007) Novel SGCE gene mutation in a Korean patient with myoclonus-dystonia with unique phenotype mimicking Moya–Moya disease. Mov Disord 22(8):1206–1207. doi:10.1002/mds.21093
Carbon M, Raymond D, Ozelius L, Saunders-Pullman R, Frucht S, Dhawan V, Bressman S, Eidelberg D (2013) Metabolic changes in DYT11 myoclonus-dystonia. Neurology 80(4):385–391. doi:10.1212/WNL.0b013e31827f0798
Thomas RH, Johnston JA, Hammond CL, Bagguley S, White C, Smith PE, Rees MI (2012) Genetic epilepsy with febrile seizures plus: definite and borderline phenotypes. J Neurol Neurosurg Psychiatry 83(3):336–338. doi:10.1136/jnnp-2011-300405
Scheffer IE, Berkovic SF (1997) Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120(Pt 3):479–490
Hirose S, Scheffer IE, Marini C, De Jonghe P, Andermann E, Goldman AM, Kauffman M, Tan NC, Lowenstein DH, Sisodiya SM, Ottman R, Berkovic SF, Genetics Commission of the International League Against E (2013) SCN1A testing for epilepsy: application in clinical practice. Epilepsia 54(5):946–952. doi:10.1111/epi.12168
Zuberi SM, Brunklaus A, Birch R, Reavey E, Duncan J, Forbes GH (2011) Genotype-phenotype associations in SCN1A-related epilepsies. Neurology 76(7):594–600. doi:10.1212/WNL.0b013e31820c309b
Beukers RJ, Contarino MF, Speelman JD, Schuurman PR, Booij J, Tijssen MA (2012) Deep brain stimulation of the pallidum is effective and might stabilize striatal D(2) receptor binding in myoclonus-dystonia. Front Neurol 3:22. doi:10.3389/fneur.2012.00022
Azoulay-Zyss J, Roze E, Welter ML, Navarro S, Yelnik J, Clot F, Bardinet E, Karachi C, Dormont D, Galanaud D, Pidoux B, Cornu P, Vidailhet M, Grabli D (2011) Bilateral deep brain stimulation of the pallidum for myoclonus-dystonia due to epsilon-sarcoglycan mutations: a pilot study. Arch Neurol 68(1):94–98. doi:10.1001/archneurol.2010.338
Cif L, Valente EM, Hemm S, Coubes C, Vayssiere N, Serrat S, Di Giorgio A, Coubes P (2004) Deep brain stimulation in myoclonus-dystonia syndrome. Mov Disord 19(6):724–727. doi:10.1002/mds.20030
Dijk JM, Tijssen MA (2010) Management of patients with myoclonus: available therapies and the need for an evidence-based approach. Lancet Neurol 9(10):1028–1036. doi:10.1016/S1474-4422(10)70193-9
Asmus F, Gasser T (2004) Inherited myoclonus-dystonia. Adv Neurol 94:113–119
Ghosh D, Indulkar S (2013) Primary myoclonus-dystonia: a diagnosis often missed in children. J Child Neurol. doi:10.1177/0883073813488677
Obeso JA, Rothwell JC, Lang AE, Marsden CD (1983) Myoclonic dystonia. Neurology 33(7):825–830
Acknowledgments
This study was supported by The Western Norway Regional Health Authority (Grant Nos. 911580 and 911816. Dr. Haugarvoll has been granted a research fellowship by the Dystonia Medical Research Foundation (DMRF).
Conflicts of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haugarvoll, K., Tzoulis, C., Tran, G.T. et al. Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation. J Neurol 261, 358–362 (2014). https://doi.org/10.1007/s00415-013-7203-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-013-7203-9